Complicating factors in the management of condyloma acuminata in HIV patients

Authors

  • Nita Damayanti Universitas Gadjah Mada
  • Devi A Susetiati Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia Gedung Radiopoetro lantai 3, Jl. Farmako Sekip Utara, Senolowo, Sinduadi, Kec. Mlati, Kabupaten Sleman, Daerah Istimewa Yogyakarta 55281, Indonesia

DOI:

https://doi.org/10.66344/jpad.31.4.2021.1727

Abstract

Condyloma Acuminata (CA) is an infectious disease with clinical manifestation of vegetation/ hyperkeratotic growth in the mucosal area and anogenital skin. More than 90% of CA cases are caused by infection of Human Papilloma Virus (HPV) type 6 or 11. Management of CA includes surgical and non-surgical therapy. However, the conventional therapy for CA have high recurrence rate, which ranges from 50-60%. Immunocompromised patients, including people with Human Immunodeficiency Virus (HIV) have higher recurrency rates compare to healthy people. Other matter arising in the management of CA in HIV patients is its resistance to conventional therapy. Success rate of CA therapy in HIV patients is related to the patient's immune response, low zinc levels in blood and also their CD4 levels.

Author Biography

Devi A Susetiati, Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia Gedung Radiopoetro lantai 3, Jl. Farmako Sekip Utara, Senolowo, Sinduadi, Kec. Mlati, Kabupaten Sleman, Daerah Istimewa Yogyakarta 55281, Indonesia

  Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia Gedung Radiopoetro lantai 3, Jl. Farmako Sekip Utara, Senolowo, Sinduadi, Kec. Mlati, Kabupaten Sleman, Daerah Istimewa Yogyakarta 55281, Indonesia

Downloads

Published

2022-03-29

How to Cite

1.
Damayanti N, Artami Susetiati D. Complicating factors in the management of condyloma acuminata in HIV patients. J Pak Assoc Dermatol [Internet]. 2022Mar.29 [cited 2026Apr.12];31(4):700-5. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1727

Issue

Vol. 31 No. 4 (2021): October - December

Section

Review Articles

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.